These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 23259514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J, Scholey A, Schweitzer I, Bousman C, Laporte E, Ng C, Murray G, Stough C.
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters].
    Herberg KW.
    Blutalkohol; 1993 Mar; 30(2):96-105. PubMed ID: 8481222
    [Abstract] [Full Text] [Related]

  • 6. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
    Heinze HJ, Münthe TF, Steitz J, Matzke M.
    Pharmacopsychiatry; 1994 Nov; 27(6):224-30. PubMed ID: 7870743
    [Abstract] [Full Text] [Related]

  • 7. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I.
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [Abstract] [Full Text] [Related]

  • 8. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M, Frittelli C, Bonanni E, Maestri M, Manca ML, Iudice A.
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [Abstract] [Full Text] [Related]

  • 9. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG.
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.
    Roth T, Eklov SD, Drake CL, Verster JC.
    Traffic Inj Prev; 2014 Jan; 15(5):439-45. PubMed ID: 24678565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J, Kavanagh DJ, Deed G, Bone KM.
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M, Klimm HD.
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH, Burke PJ.
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.